Haemonetics Corporation, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced the election of Lloyd E. Johnson to its Board of Directors.
Johnson served as Global Managing Director, Finance and Internal Audit at Accenture Corporation from 2004 until his retirement in 2015, where he led the global management consulting company’s audit organization and provided strategic leadership in finance, risk, compliance and governance. Prior to joining Accenture, Johnson served as Executive Director, M&A and General Auditor for Delphi Automotive PLC, a global automotive technology industry leader. He has also held senior financial leadership positions at Emerson Electric Corporation, Sara Lee Corporation and Shaw Food Services. Johnson currently serves on the boards of Apogee Enterprises, Inc.; Beazer Homes USA, Inc.; AARP, where he is second Vice Chair; and the NACD Carolinas Chapter.
“With over 35 years of senior finance leadership experience, Lloyd brings significant expertise and strategic insight to the Board in the areas of accounting and financial management, mergers and acquisitions, international operations, business development, corporate governance and enterprise risk management,” said Ellen Zane, Chair of Haemonetics’ Board of Directors. “We look forward to welcoming him to our Board of Directors as Haemonetics pursues its strategies to deliver shareholder value.”
Johnson earned his bachelor’s and master’s degrees from the University of South Carolina and a Master of Business Administration from Duke University. He was named one of the “Most Influential Black Corporate Directors” by Savoy in 2017 and has been listed as a “Director to Watch” in 2018 and 2020 by Directors & Boards.
